6.760
+1,35%
2026-10-19
Fundamental Analysis
74 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +7065.5% | +2394.0% | 2 / 3 | +23.7% | -9.21 pp | +9.16 pp | +6.0% | 0.06 | 6.27 | 82,2 | +23,7% | 7,4 | +7.065,5% | 6.27 | 11.85 | −47,1% |
| Pts | 12 | 12 | 8 | 12 | 0 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 6.760 (close price on 2026-10-19)EPS (TTM): 1.078
Financial charts
1.Revenue & growth
VND bn82,2Q2/26
1.Revenue & growth
VND bn82,2Q2/26
2.Profit & growth
VND bn9,50Q2/26
3.Profit mix (Penman)
VND bn73,2Q2/26
4.Margins & cost structure
%16.1%Q2/26
5.Returns & cash cycle
% · days0.3%Q2/26
6.Earnings quality & cash
VND bn145Q2/26
7.Asset structure
VND bn1.214Q2/26
8.Funding & debt health
VND bn · times1.214Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %6,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %157Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
58.3%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26